Quantitative image based analysis of endocrine disruptor effects on mitochondria morphology-function in prostate cancer cells
Aurélie Charazac, Nicolas Chevalier(Inserm), Mamadou Guèye, Frédéric Bost(Inserm), Jérôme Gilleron(Université Clermont Auvergne), Stéphan Clavel(Centre Intégré de Santé et de Services Sociaux des Laurentides), Célia Decondé Le Butor(Inserm), Kévin Giuletti(Université Clermont Auvergne), Patrick Fénichel(Inserm), Xavier Descombes, Maéva Gesson(Centre Méditerranéen de Médecine Moléculaire)
INRIA a CCSD electronic archive server
May 9, 2017
Cited by 0
Related Papers
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
|Oncogene|2008|852
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
|Cancer Research|2011|620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
|Molecular Cancer Therapeutics|2010|490